Course Description
Major disease epidemics are typically associated with overcrowded living conditions, inadequate food storage, food-borne illnesses, and food safety issues. However, early disease spread did not spread very far due to the inability to travel across continents. Over time, epidemics became pandemics, and disease development and transmission transitioned from local spread to international exposure, as rail and ship travel made long-distance travel possible. Since early 2020, this scenario has been playing out as a newly discovered virus, COVID-19 and its variants, became an international pandemic after the original virus was first discovered in December 2019.

From the first diagnosed patient up to the present day, the way clinicians and healthcare providers of all types diagnose, treat, and manage patients with COVID-19 has evolved. The importance that radiological imaging plays has been key to effectively treating patients of all ages and with varying comorbidities, particularly pediatric patients. As a result, it is critical that all radiology healthcare professionals are well educated and well versed in performing the necessary imaging studies that help diagnose and treat pediatric patients with COVID-19 and its associated conditions. This includes their role as consultants in advising clinicians on the appropriate use of chest radiography, computed tomography (CT), and lung sonography (LUS) as diagnostic tools. It is also important for radiologic technologists (RTs) to produce the highest quality diagnostic studies for the subtle findings of COVID-19 to be interpreted by the radiologist. This course will provide up-to-date information about the development of COVID-19 since its discovery, disease spread, vaccine types and approvals for pediatric patients, and infection control procedures and protocols. It will also address the possible complications of COVID-19 diagnosis, related conditions and disease courses, and how chest X-rays, CT, and LUS best assist healthcare professionals in the most effective treatment and management of infants, children, and adolescents.  

Learning Objectives

After completing this course, the participant should be able to:

• OUTLINE the epidemiology, transmission, symptoms, infection control techniques, and vaccination/testing information of COVID-19.
• DESCRIBE multisystem inflammatory syndrome in children and "Long COVID," their symptoms, diagnosis, and treatment strategies.
• SUMMARIZE the mental health effects of COVID-19 on children and adolescent patients.
• OUTLINE and EXPLAIN the roles that CT, lung ultrasound, and radiography play in assessing and diagnosing pediatric patients with suspected COVID-19.
• IDENTIFY the radiologic manifestations of COVID-19 and associated illness on CT, lung ultrasound, and chest X-ray.
• DISTINGUISH the similarities and differences between COVID-19 in pediatric and adult patients.

Categories: Radiology, Computed Tomography, Digital Radiography, Sonography

In order to receive CE credit, you must first complete the activity content. When completed, go to the "Take CE Test!" link to access the post-test.

Submit the completed answers to determine if you have passed the post-test assessment. You must answer 20 out of 26 questions correctly to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test.

Participants successfully completing the activity content and passing the post-test will receive 2.5 ARRT Category A credits.

Approved by the American Society of Radiologic Technologists for ARRT Category A credit.

Approved by the state of Florida for ARRT Category A credit.

Texas direct credit.

This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.

For ACCME Credit

Release Date: 5/25/2022

Expiration Date: 5/25/2024

Target Audience
This activity is designed to meet the needs of Radiologic Technologists and Physicians, specifically Radiologists.

Criteria for Success
In order to receive credit, participants should review the content and continue to the post-test and evaluation. A certificate will generate upon successful submission of the post-test and evaluation. If you have questions about this CME activity, please contact AKH Inc. wendi@akhcme.com.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.  This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and eRADIMAGING.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and eRADIMAGING. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
There is no commercial support for this activity.

Disclosures

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The planners and faculty must disclose to the participants any significant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." or with the commercial supporter of this accredited continuing education activity. Identified conflicts of interest are mitigated by AKH prior to the planners/faculty assuming their role in this accredited continuing education activity.

Disclosure of Unlabeled Use and Investigational Products
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.